SIAP
AVEO

Sterling Investment Advisors (Pennsylvania)’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Sterling Investment Advisors (Pennsylvania)’s Portfolio AVEO Stock Details AVEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-6
Closed – – 583
2022
Q2 		$0 Hold
6
– – ﹤0.01% 659
2022
Q1 		$0 Hold
6
– – ﹤0.01% 642
2021
Q4 		$0 Hold
6
– – ﹤0.01% 638
2021
Q3 		$0 Hold
6
– – ﹤0.01% 624
2021
Q2 		$0 Hold
6
– – ﹤0.01% 595
2021
Q1 		$0 Hold
6
– – ﹤0.01% 556
2020
Q4 		$0 Hold
6
– – ﹤0.01% 495
2020
Q3 		$0 Hold
6
– – ﹤0.01% 479
2020
Q2 		$0 Hold
6
– – ﹤0.01% 459
2020
Q1 		$0 Sell
6
-1
-14% -$5 ﹤0.01% 464
2019
Q4 		$0 Hold
7
– – ﹤0.01% 459
2019
Q3 		$0 Hold
7
– – ﹤0.01% 458
2019
Q2 		$0 Hold
7
– – ﹤0.01% 458
2019
Q1 		$0 Hold
7
– – ﹤0.01% 441
2018
Q4 		$0 Hold
7
– – ﹤0.01% 444
2018
Q3 		$0 Hold
7
– – ﹤0.01% 443
2018
Q2 		$0 Hold
7
– – ﹤0.01% 412
2018
Q1 		$0 Buy
+7
New +$205 ﹤0.01% 384

Other funds holding AVEO

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.82% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return
GC
Globeflex Capital San Diego, California $661M AUM 50.59% 1-Year Est. Return

Sterling Investment Advisors (Pennsylvania)'s AVEO Position: Q3 2022 in Review

Sterling Investment Advisors (Pennsylvania) sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q3 2022, closing a stake of 6 shares.

Sterling Investment Advisors (Pennsylvania) first reported a position in AVEO in Q1 2018 and held it in 18 quarters. The position peaked at $0 in Q2 2022. 77 funds tracked by Wall St. Rank hold AVEO as of Q3 2022.

  • Sterling Investment Advisors (Pennsylvania) reported no remaining AVEO Pharmaceuticals, Inc. position as of Q3 2022 after selling out during the quarter.
  • Sterling Investment Advisors (Pennsylvania) sold 6 AVEO Pharmaceuticals, Inc. shares in Q3 2022.
  • Sterling Investment Advisors (Pennsylvania) first reported a position in AVEO Pharmaceuticals, Inc. in Q1 2018 and held it in 18 quarters.
  • Sterling Investment Advisors (Pennsylvania)'s AVEO Pharmaceuticals, Inc. position peaked at $0 in Q2 2022.
  • 77 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q3 2022.

Based on Sterling Investment Advisors (Pennsylvania)'s 13F filing for Q3 2022, filed 3 Nov 2022.